Seeking Alpha

alancherry50

alancherry50
Send Message
View as an RSS Feed
View alancherry50's Comments BY TICKER:
Latest  |  Highest rated
  • Durata jumps as investors realize the potential benefits of Angelini deal [View news story]
    just the beginning this stock will fly wait till 2015 when profits rolll in and EMA approves it
    Aug 4 03:56 PM | 1 Like Like |Link to Comment
  • Arena Conference Call Sets Stage For Near Term Equity Movement [View article]
    Spencer you need to look at facts this company is a dead stock realize it and stop putting all these false hopes up here
    Jul 28 06:51 PM | 1 Like Like |Link to Comment
  • Arena Sees Belviq Sales Climb Despite Seasonality [View article]
    how much longer are you going to lead these people on about this dead stock
    Jul 27 09:04 PM | 2 Likes Like |Link to Comment
  • Arena Needs To Hold Eisai Accountable For Re-Launch Of Belviq [View article]
    Spencer you need to move on its obvious that Arena will never make it
    Jul 1 09:34 PM | 1 Like Like |Link to Comment
  • Orexigen Could Be A Double-Edged Sword For Arena [View article]
    you all seem to forget that orex has the way upperhand because Takeda already has 900 reps out there already seeing these doctors because of their diabetes drug remember. What is one of the leading causes of diabetes um obesity you think.Vivus and Arena will eventually lose out almost entirely to Orexigen they just have to much in their favor
    Jun 10 09:54 AM | Likes Like |Link to Comment
  • Orexigen Could Be A Double-Edged Sword For Arena [View article]
    Takeda is big pharma last time I checked
    Jun 10 09:53 AM | Likes Like |Link to Comment
  • Arena's Belviq Sales Continue Up As Others Decline [View article]
    osbourne you are a die hard but it time to face reality
    Feb 23 09:40 PM | Likes Like |Link to Comment
  • Sarepta Therapeutics: Irrational Exuberance [View article]
    lets just wait and see let the DEAdo the talking.Alltheses comments dont mean a thing
    Apr 25 08:38 AM | Likes Like |Link to Comment
  • Cisco's (CSCO) software push extends to its slumping collaboration systems unit: a product refresh includes software for adjusting the resources allocated to collaboration gear based on device type, and integrates Cisco's WebEx  online conferencing software with its TelePresence hardware - WebEx users can be patched into TelePresence meetings, and content shared between the platforms. Cisco's collaboration sales fell 11% Y/Y in FQ2, and have been pressured by upstarts such as Vidyo and Blue Jeans Network. Rival Polycom (PLCM) has also been struggling. [View news story]
    whoever you are you do not have a clue Cisco is probably one of the top ten stocks out there do your homework.
    Mar 21 02:27 AM | Likes Like |Link to Comment
COMMENTS STATS
9 Comments
5 Likes